Back
GT Biopharma Vs. Apogee Enterprises Industry Stock Comparison
Buy
55
GTBP
GT Biopharma
Last Price:
2.95
Seasonality Move:
-2.25%
Buy
53
APOG
Apogee Enterprises
Last Price:
76.76
Seasonality Move:
6.63%
Buy
55
GT Biopharma (GTBP)
is a Buy
Is GT Biopharma a Buy, Sell or Hold?
- The current GT Biopharma [GTBP] share price is $2.97. The Score for GTBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- GTBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Apogee Enterprises (APOG)
is a Buy
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $75.80. The Score for APOG is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- APOG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GTBP Stock Price Chart
What is GT Biopharma's stock price today?
-
The GT Biopharma share price today is $2.97
The current trend is moderately bullish and GTBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $75.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APOG is experiencing buying pressure, which is a positive indicator for future bullish movement.
GTBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 64.59 | Buy |
| Chaikin Money Flow: | 1938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.98 - 2.9) | Buy |
| Bollinger Bands (100): | (2.1 - 2.86) | Buy |
APOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 53.61 | Buy |
| Chaikin Money Flow: | 98818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.01 - 79.47) | Buy |
| Bollinger Bands (100): | (60.72 - 72.74) | Buy |
GTBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.08 | Sell |
| 20-day SMA: | 2.51 | Buy |
| 50-day SMA: | 2.28 | Buy |
| 200-day SMA: | 3.39 | Sell |
| 8-day EMA: | 2.95 | Buy |
| 20-day EMA: | 2.67 | Buy |
| 50-day EMA: | 2.47 | Buy |
| 200-day EMA: | 4.36 | Sell |
APOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.45 | Buy |
| 20-day SMA: | 77.32 | Sell |
| 50-day SMA: | 70.77 | Buy |
| 200-day SMA: | 62.89 | Buy |
| 8-day EMA: | 75.81 | Sell |
| 20-day EMA: | 75.31 | Buy |
| 50-day EMA: | 71.94 | Buy |
| 200-day EMA: | 63.45 | Buy |
GT Biopharma Earnings Growth & GTBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.43 per share.
GT Biopharma Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Enterprises Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||